期刊文献+
共找到66篇文章
< 1 2 4 >
每页显示 20 50 100
Secretory carcinoma——impact of translocation and gene fusions on salivary gland tumor
1
作者 Ryoko Inaki Masanobu Abe +4 位作者 Liang Zong Takahiro Abe Aya Shinozaki-Ushiku Tetsuo Ushiku Kazuto Hoshi 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2017年第5期379-384,共6页
Secretory carcinoma(SC), previously described as mammary analogue secretory carcinoma(MASC), is a recently described salivary gland tumor which morphologically resembles mammary secretory carcinoma. The first desc... Secretory carcinoma(SC), previously described as mammary analogue secretory carcinoma(MASC), is a recently described salivary gland tumor which morphologically resembles mammary secretory carcinoma. The first description of SC/MASC, reported by Skálová et al. in 2010, was as a rare salivary carcinoma imitating secretory carcinoma of the breast. SC/MASC is a unique salivary gland tumor with morphological overlap with acinic cell carcinoma(Aci CC), mucoepidermoid carcinoma(MEC), and adenocarcinoma not otherwise specified(ADCNOS). SC/MASC shares similar clinicopathological features with Aci CC. As a critical difference between SC/MASC and Aci CC, SC/MASC characteristically has the chromosomal translocation t(12;15)(p13;q25) which leads to a fusion gene between the ETV6 gene on chromosome 12 and the NTRK3 gene on chromosome 15. This genetic background is an important differential diagnostic finding for excluding other salivary gland tumors and may be a critical factor determining the prognosis for patients with SC/MASC. Research in recent years has provided a large body of new data on SC/MASC and suggests the possibility that the ETV6-NTRK3 translocation could be a therapeutic target. Here, we review the morphological and clinicopathological features of SC/MASC and discuss new directions for therapy. 展开更多
关键词 secretory carcinoma mammary analogue secretory carcinoma MASC ETV6-NTRK3 fusion gene salivary gland tumor
下载PDF
Parotid mammary analogue secretory carcinoma:A case report and review of literature 被引量:1
2
作者 Feng-He Min Jia Li +7 位作者 Bo-Qiang Tao Hui-Min Liu Zhi-Jing Yang Lu Chang Yu-Yang Li Ying-Kun Liu Yi-Wen Qin Wei-Wei Liu 《World Journal of Clinical Cases》 SCIE 2021年第16期4052-4061,共10页
BACKGROUND Mammary analogue secretory carcinoma(MASC)is a rare low-grade malignant salivary gland tumor.The morphological and immunohistochemical features of MASC closely resemble those of breast secretory carcinoma.T... BACKGROUND Mammary analogue secretory carcinoma(MASC)is a rare low-grade malignant salivary gland tumor.The morphological and immunohistochemical features of MASC closely resemble those of breast secretory carcinoma.The key characteristics of the lesion are a lack of pain and slow growth.There is no obvious specificity in the clinical manifestations and imaging features.The diagnosis of the disease mainly depends on the detection of the MASC-specific ETV6-NTRK3 fusion gene.CASE SUMMARY This report describes a rare case of a 32-year-old male patient who presented with a gradually growing lesion that was initially diagnosed as breast-like secretory carcinoma of the right parotid gland.Imaging and histological investigations were used to overcome the diagnostic difficulties.The lesion was managed with right parotidectomy,facial nerve preservation,biological patch implantation to restore the resulting defect,and postoperative radiotherapy.On postoperative follow-up,the patient reported a mild facial deformity with no complications,signs of facial paralysis,or Frey’s syndrome.CONCLUSION The imaging and histological diagnostic challenges for MASC are discussed. 展开更多
关键词 Mammary analogue secretory carcinoma salivary gland IMMUNOHISTOCHEMISTRY Total lobectomy of right parotid gland Case report
下载PDF
Postoperative radiotherapy for thymus salivary gland carcinoma:A case report
3
作者 Rui Deng Nan-Jing Li +3 位作者 Liang-Liang Bai Shi-Hong Nie Xiao-Wen Sun Yong-Sheng Wang 《World Journal of Clinical Cases》 SCIE 2022年第26期9484-9492,共9页
BACKGROUND Salivary gland cancer is a rare disease in which cancer cells form in the tissues of the salivary glands.It mostly occurs in the glands that have secretion functions,such as the parotid gland,sublingual gla... BACKGROUND Salivary gland cancer is a rare disease in which cancer cells form in the tissues of the salivary glands.It mostly occurs in the glands that have secretion functions,such as the parotid gland,sublingual gland and submandibular gland.This is very rare when it occurs in other nonsecreting glands.Here,we report one case of salivary gland carcinoma occurring in the thymus and discuss related diagnoses and treatment progress.CASE SUMMARY One 33-year-old middle-aged man presented with a thymus mass without any clinical symptoms when he underwent regular physical examination.Later,the patient was admitted to the hospital for further examination.Computed tomography(CT)showed that there was a mass of 3 cm×2.8 cm×1.5 cm in the thymus area.The patient had no symptom of discomfort or tumor-related medical history before.After completing the preoperative examinations,it was confirmed that the patient had indications for surgery.The surgeon performed a transthoracoscope"thymectomy+pleural mucostomy"for him.During the operation,the tumor tissue was quickly frozen,and the symptomatic section showed a malignant tumor.The final pathological result suggested thymus salivary gland carcinoma-mucoepidermoid carcinoma(MEC).In the second month after surgery,we performed local area radiotherapy for the patient,with a total radiation dose of 50.4 Gy/28Fx.After 12 mo of surgery,the patient underwent positron emission tomography-CT examination,which indicated that there was no sign of tumor recurrence or metastasis.After 16 mo of operation,CT scan re-examination showed that there was no sign of tumor recurrence or metastasis.As of the time of publication,the patient was followed up for one and a half years.He had no sign of tumor recurrence and continued to survive.CONCLUSION The incidence of MEC in the thymus is low,and its diagnosis needs to be combined with clinical features and imaging methods.Histopathological analysis plays a key role in the diagnosis of the disease.Patients with early-stage disease have a good prognosis and long survival period.In contrast,patients with advanced-stage disease have a poor prognosis and short survival period.Combining radiotherapy and chemotherapy in inoperable patients may prolong survival. 展开更多
关键词 Thymic tumor salivary gland carcinoma Mucoepidermoid carcinoma POSTOPERATIVE RADIOTHERAPY Case report
下载PDF
Adenoid Cystic Carcinoma of Parotid Salivary Gland—A Case Study
4
作者 Shuaib Kayode Aremu 《Case Reports in Clinical Medicine》 2018年第11期576-581,共6页
Adenoid Cystic Carcinoma (ACC) is an infrequent slow growing epithelial tumour constituting for around less than 1% of all the oral and maxillo-facial malignancies and almost 10% of all the salivary gland tumors. Paro... Adenoid Cystic Carcinoma (ACC) is an infrequent slow growing epithelial tumour constituting for around less than 1% of all the oral and maxillo-facial malignancies and almost 10% of all the salivary gland tumors. Parotid gland is the second most common site to be involved in the head and neck region along with submandibular gland, Palate being the most common site involved in the oral cavity. Key feature of these tumors include its asymptomatic presentation, indolent nature, typically showing infiltrative growth and peri-neural invasion. Herein, we report a case of adenoid cystic carcinoma of right parotid gland of a 33-year-old male who presented with complaint of painless slow enlargement of left parotid gland and facial muscle weakness. On Examination firm mass in the region of the left parotid gland as well as left facial paralysis was seen. Biopsy results and further management is discussed here within. 展开更多
关键词 ADENOID CYSTIC carcinoma PAROTID gland MALIGNANT salivary gland tumor
下载PDF
Effective chemotherapy for submandibular gland carcinoma ex pleomorphic adenoma with lung metastasis after radiotherapy: A case report
5
作者 Zhi-Yuan Chen Yu Zhang +2 位作者 Yan Tu Wei Zhao Mei Li 《World Journal of Clinical Cases》 SCIE 2019年第6期792-797,共6页
BACKGROUND Only a few cases of carcinoma ex pleomorphic adenoma arising in the submandibular gland have ever been reported,all with a poor prognosis. The standard treatment for salivary gland carcinoma ex pleomorphic ... BACKGROUND Only a few cases of carcinoma ex pleomorphic adenoma arising in the submandibular gland have ever been reported,all with a poor prognosis. The standard treatment for salivary gland carcinoma ex pleomorphic adenoma is surgical resection combined with postoperative radiotherapy,but the necessity of chemotherapy as well as the most appropriate treatment regimen for patients with distant metastasis after radiotherapy remains controversial.CASE SUMMARY This report presents the case of a 73-year-old woman who suffered submandibular gland carcinoma ex pleomorphic adenoma. She accepted surgery to remove the mass; she was found to have lung metastasis after radiotherapy.Her condition was controlled by chemotherapy with liposomal doxorubicin plus cisplatin.CONCLUSION The positive clinical outcome in the patient reveals that this chemotherapy regimen may be an alternative treatment for such a condition. 展开更多
关键词 MALIGNANT PLEOMORPHIC ADENOMA salivary gland tumors CHEMOTHERAPY carcinoma ex PLEOMORPHIC ADENOMA Case report
下载PDF
Atypical Cystic Parotid Gland Acinic Cell Carcinoma in a Child
6
作者 Noah N. Chasen Peter Kalina 《Advances in Computed Tomography》 2013年第2期52-54,共3页
Purpose: To describe the extremely rare occurrence of acinic cell carcinoma of the parotid in a young child. Materials & Methods: A 14-year-old boy presented with a left sided facial mass. It was initially thought... Purpose: To describe the extremely rare occurrence of acinic cell carcinoma of the parotid in a young child. Materials & Methods: A 14-year-old boy presented with a left sided facial mass. It was initially thought to be a bug bite or perhaps a wrestling injury. However, it progressed rapidly overall several weeks. CT revealed a well-circumscribed, cystic, 3.9 × 2.8 × 3.2 cmmass centered in the deep lobe of the left parotid gland, also involving the superficial lobe and extending medially through the stylomandibular tunnel with a component extending to the stylomastoid foramen. There was no solid enhancing portion. There were several enlarged level II lymph nodes suspicious for nodal metastases. Results: The mass was biopsied and pathology was consistent with acinic cell carcinoma. Complete left parotidectomy and left selective neck dissection was performed, confirming the diagnosis. Conclusions: Salivary gland neoplasms are rare in children. Less than 5% of salivary gland tumors occur in children. Salivary gland neoplasms account for less than 8% of pediatric head and neck tumors. Approximately 1/3 of salivary gland tumors arising in childhood are malignant;most being mucoepidermoid. Acinic cell carcinoma of the parotid gland in children is extremely rare, especially in those under age 16, with only a few available case reports. This case was also unusual in that the lesion was predominantly cystic. 展开更多
关键词 Acinic Cell carcinoma PAROTID gland salivary gland tumorS
下载PDF
8例涎腺分泌性癌的临床病理分析及预后
7
作者 师晓莉 古丽给娜·胡阿提 马遇庆 《新疆医学》 2024年第3期255-258,274,共5页
目的研究涎腺分泌性癌(secretory carcinoma of salivary gland,SCSG)的临床表现、病理学特点、鉴别诊断及预后。方法收集2021年1月-2023年9月新疆医科大学第一附属医院病理科确诊的8例SCSG,从组织学、免疫组织化学及分子检测多方面研... 目的研究涎腺分泌性癌(secretory carcinoma of salivary gland,SCSG)的临床表现、病理学特点、鉴别诊断及预后。方法收集2021年1月-2023年9月新疆医科大学第一附属医院病理科确诊的8例SCSG,从组织学、免疫组织化学及分子检测多方面研究分析。结果8例SCSG患者男女各4例,年龄21岁-84岁,中位年龄51岁,肿瘤直径1.5 cm-6.5 cm,临床上以缓慢生长的无痛性肿块为首发症状,所有患者均行手术切除。组织学以微囊状、管状-乳头状或实性结构为主。8例弥漫表达细胞角蛋白(CK)7和S-100蛋白,6例乳腺球蛋白阳性、1例部分阳性及1例仅个别细胞阳性;6例pan-Trk阳性,1例阴性,GCDFP153例阴性、1例部分阳性及1例个别细胞阳性;SOX-10阳性3例、2例阴性;Ki-67阳性指数3%-20%。8例均有ETV6-NTRK3融合基因信号。结论SCSG是一种较罕见的低度恶性涎腺源性肿瘤,具有典型组织学和免疫表型,pan-Trk免疫组织化学可能与NTRK融合相关,ETV6-NTRK3基因重排不但具有诊断意义,同时Trk靶向治疗有望在临床治疗中发挥更大作用。 展开更多
关键词 涎腺分泌性癌 免疫组织化学 基因融合 诊断
下载PDF
涎腺分泌性癌临床病理特征分析并文献复习(附4例)
8
作者 暴欣然 徐晓艳 +2 位作者 马萍 杨一航 孟汀芳 《现代肿瘤医学》 CAS 2024年第8期1435-1439,共5页
目的:研究并探讨涎腺分泌性癌(secretory carcinoma,SC)的临床病理特征、免疫表型、鉴别诊断、治疗及预后。方法:对4例涎腺分泌性癌进行HE染色和免疫组化染色,收集分析4例涎腺分泌性癌的临床资料并复习相关文献。结果:4例肿瘤均发生在腮... 目的:研究并探讨涎腺分泌性癌(secretory carcinoma,SC)的临床病理特征、免疫表型、鉴别诊断、治疗及预后。方法:对4例涎腺分泌性癌进行HE染色和免疫组化染色,收集分析4例涎腺分泌性癌的临床资料并复习相关文献。结果:4例肿瘤均发生在腮腺,患者年龄为30岁~55岁,中位年龄为40岁;肿瘤直径为0.5 cm~3.0 cm;肿瘤组织均界限清楚,2例大部分切面灰白实性,质地中等;1例切面实性,灰粉灰黄相杂,质软易碎;1例呈囊实性改变,实性区质软灰粉色。镜下观察,肿瘤细胞排列成多种结构,可呈微囊、大囊及腺管内乳头状排列。肿瘤细胞界限不清,胞浆丰富,呈嗜酸性或空泡状,具有圆形或卵圆形的细胞核,核仁明显,核分裂象及坏死少见。4例肿瘤细胞CK5/6、p63均为阴性表达,肿瘤细胞均弥漫强表达S100、Mammaglobin,弥漫表达CKAE1/AE3、CK7、CK8、Vimentin,大部分肿瘤区域DOG1表达缺失,仅在少数瘤巢周或腔缘弱阳性,而Ki67增殖指数约10%。结论:发生于涎腺的分泌性癌类似于乳腺的分泌性癌,是一种少见的低度恶性肿瘤,由于其典型的形态学特征,并结合免疫组化结果即可做出诊断。ETV6-NTRK3基因检测可辅助诊断,治疗以手术切除为主辅以放化疗,预后较好。 展开更多
关键词 涎腺 分泌性癌 病理学特征
下载PDF
Hyalinizing clear cell carcinoma-a rare entity in the oral cavity: A case report 被引量:1
9
作者 Alejandro Donohue-Cornejo Oslei Paes de Almeida +3 位作者 Celeste Sánchez-Romero León Francisco Espinosa-Cristóbal Simón Yobanny Reyes-López Juan Carlos Cuevas-González 《World Journal of Clinical Cases》 SCIE 2020年第1期133-139,共7页
BACKGROUND Hyalinizing clear cell carcinoma(HCCC)is an uncommon tumor that originates in the salivary glands.This neoplasia constitutes less than 1%of minor salivary gland tumors.CASE SUMMARY A 67-year-old female visi... BACKGROUND Hyalinizing clear cell carcinoma(HCCC)is an uncommon tumor that originates in the salivary glands.This neoplasia constitutes less than 1%of minor salivary gland tumors.CASE SUMMARY A 67-year-old female visited the maxillofacial surgery department owing to a smooth,slightly yellowish protruding mass on the left side of the floor of the mouth,at the level of the molars;the tumor mass had a soft consistency on palpation and did not adhere to deep planes.The microscopical analysis of the excisional biopsy showed that the lesion was composed of sheets and cords of clear cells separated by thick eosinophilic bands of hyaline collagen.Normal glandular tissue was absent,periodic acid-Schiff with and without diastase stains,and immunohistochemical reactions were performed to confirm the diagnosis.This is the second case reported in the literature of HCCC arising in the floor of the mouth.CONCLUSION HCCC is a rare salivary gland tumor that has not been studied extensively.Its diagnosis is usually challenging,because clinically,it can be confused with a benign neoplasm. 展开更多
关键词 Hyalinizing clear cell carcinoma salivary gland tumor Immunohistochemical reactions Case report
下载PDF
软腭唾液腺分泌性癌1例并文献复习
10
作者 袁亚晨 赵立仙 +3 位作者 潘云 李正金 李耀康 高波 《临床与病理杂志》 CAS 2024年第4期628-635,共8页
唾液腺分泌性癌(secretory carcinoma of salivary glands,SCSG)是一种罕见的恶性唾液腺肿瘤。2023年2月,大理大学第一附属医院收治1例左侧软腭见1个肿物的35岁女性患者。显微镜下该肿物形成微囊状、小管状结构,腔隙内充满嗜酸性胶样分... 唾液腺分泌性癌(secretory carcinoma of salivary glands,SCSG)是一种罕见的恶性唾液腺肿瘤。2023年2月,大理大学第一附属医院收治1例左侧软腭见1个肿物的35岁女性患者。显微镜下该肿物形成微囊状、小管状结构,腔隙内充满嗜酸性胶样分泌物。免疫组织化学(immunohistochemistry,IHC)示:广谱原肌球蛋白受体激酶(pantropomyosin receptor kinase,pan-TRK)、乳腺球蛋白(mammaglobin)、S100钙结合蛋白(S100 calcium binding protein,S100)均阳性,钙激活氯通道蛋白1(anoctamin-1,ANO1)阴性。荧光原位杂交(fluorescence in situ hybridization,FISH)示:ETS变异转录因子6(ETS variant transcription factor 6,ETV6)基因断裂阳性,ETV6-神经酪氨酸激酶受体3(neurotrophic receptor tyrosine kinase 3,NTRK3)基因融合阳性,MET原癌基因受体酪氨酸激酶(MET proto-oncogene,receptor tyrosine kinase,MET)基因断裂阴性。患者最终被诊断为SCSG,随后接受了“左侧腭部肿物切除术+邻近皮瓣修复术”,截至2024年2月未见复发或转移。本文回顾性分析1例发生于软腭的SCSG,并总结此前国内外发生于软腭的SCSG共12例。 展开更多
关键词 唾液腺肿瘤 唾液腺分泌性癌 广谱原肌球蛋白受体激酶 ETV6-NTRK3基因融合
下载PDF
唾液腺腺样囊性癌微环境中肿瘤相关巨噬细胞外泌体差异表达miRNAs的筛选及验证
11
作者 惠琪 高万鹏 +5 位作者 李欢 赵琦 王珺 魏建华 杨新杰 杨子桧 《中国口腔颌面外科杂志》 CAS 2024年第3期209-215,共7页
目的:探讨唾液腺腺样囊性癌(salivary adenoid cystic carcinoma,SACC)微环境中肿瘤相关巨噬细胞(tumor-associated macrophages,TAMs)外泌体miRNAs表达特征,分析其在SACC进展中的作用。方法:将SACC细胞与巨噬细胞共培养,获得SACC相关T... 目的:探讨唾液腺腺样囊性癌(salivary adenoid cystic carcinoma,SACC)微环境中肿瘤相关巨噬细胞(tumor-associated macrophages,TAMs)外泌体miRNAs表达特征,分析其在SACC进展中的作用。方法:将SACC细胞与巨噬细胞共培养,获得SACC相关TAMs。应用超速离心法分别提取以上细胞外泌体,采用透射电镜、Western免疫印迹、外泌体纳米微粒追踪检测进行验证。对TAMs外泌体与对照组巨噬细胞外泌体进行RNA-seq测序,分析差异表达的miRNAs。利用miRanda和RNAhybrid软件对差异miRNAs进行靶基因预测,再对差异miRNAs作用的靶基因的集合分别进行GO和KEGG富集分析。利用qRT-PCR、CCK-8、细胞划痕实验、Transwell实验验证TAMs外泌体miRNAs表达及功能。采用SPSS 22.0软件包对数据进行统计学分析。结果:筛选出1595个差异表达的miRNAs,其中15个miRNAs表达差异变化具有统计学意义(P<0.05)。差异miRNAs作用靶基因富集分析发现,TAMs外泌体miRNAs靶基因参与调控癌症相关信号通路。qRT-PCR结果显示,TAMs外泌体has-miR-21-5p表达上调最显著。CCK-8、细胞划痕实验和Transwell实验发现,TAMs外泌体hsa-miR-21-5p促进SACC细胞增殖、迁移与侵袭能力。结论:TAMs外泌体hsa-miR-21-5p促进SACC细胞恶性进展。TAMs外泌体miRNAs可能在SACC进展中发挥重要作用,有望为SACC的诊治提供新的策略。 展开更多
关键词 唾液腺 腺样囊性癌 肿瘤相关巨噬细胞 外泌体 MIRNAS hsa-miR-21-5p
下载PDF
S100蛋白和CD43在涎腺腺样囊性癌和基底细胞腺瘤中的表达及意义
12
作者 鲁华东 姜秋利 +1 位作者 张福汉 许建芳 《深圳中西医结合杂志》 2024年第11期1-3,I0004,共4页
目的:探讨S100蛋白和簇分化抗原(CD)43免疫组化标记在涎腺腺样囊性癌(ACC)和基底细胞腺瘤(BCA)中的表达及意义。方法:收集复旦大学附属中山医院厦门医院2018年1月至2023年12月间手术切除的21例ACC和8例BCA患者病灶标本,采用免疫组化EnVi... 目的:探讨S100蛋白和簇分化抗原(CD)43免疫组化标记在涎腺腺样囊性癌(ACC)和基底细胞腺瘤(BCA)中的表达及意义。方法:收集复旦大学附属中山医院厦门医院2018年1月至2023年12月间手术切除的21例ACC和8例BCA患者病灶标本,采用免疫组化EnVision两步法行S100蛋白和CD43免疫组化染色并分析表达情况。结果:S100蛋白标记显示所有ACC病例均未见S100蛋白阳性的梭形细胞间质(0.0%),BCA可见S100蛋白强阳性的梭形细胞间质(62.5%),差异具有统计学意义(P<0.01);CD43标记显示ACC肿瘤细胞CD43阳性表达率为71.4%,而BCA肿瘤细胞CD43阳性表达率为12.5%,差异具有统计学意义(P=0.01)。结论:联合S100蛋白和CD43免疫组化标记有助于涎腺ACC和BCA的鉴别诊断。 展开更多
关键词 腺样囊性癌 基底细胞腺瘤 涎腺肿瘤 S100蛋白 簇分化抗原43
下载PDF
涎腺腺样囊性癌的临床特征及预后分析 被引量:1
13
作者 田绣云 周美云 +4 位作者 韩瑞 李婕 罗彬 陈鑫如 徐锦程 《医学研究杂志》 2023年第6期108-111,116,共5页
目的分析涎腺腺样囊性癌(salivary adenoid cystic carcinoma,SACC)患者的临床特征,探究其与预后的相关性。方法回顾性分析收集2016年1月~2021年1月就诊于笔者医院口腔科腺样囊性癌患者的病例资料38例,采用统计学方法分析研究其临床特... 目的分析涎腺腺样囊性癌(salivary adenoid cystic carcinoma,SACC)患者的临床特征,探究其与预后的相关性。方法回顾性分析收集2016年1月~2021年1月就诊于笔者医院口腔科腺样囊性癌患者的病例资料38例,采用统计学方法分析研究其临床特征和预后。结果SACC好发生于腭部、口底等部位,平均年龄为56.7岁,易转移至肺部、骨组织及肝脏等部位,其中T_(3)和T_(4)分期的患者有17例(44.7%),22例(57.9%)有神经侵袭(perineural invasion,PNI),17例(44.7%)侵犯淋巴结,术后复发13例(34.2%),PNI与术后复发有一定的相关性(P<0.05),淋巴结侵犯与生存率无相关性(P>0.05),手术切缘阳性和术后复发对预后生存率相关(P<0.05),5年生存率为73.7%。结论SACC是一种常见的涎腺恶性肿瘤,SACC手术切缘阳性、术后复发与预后生存率差异有统计学意义,淋巴结侵犯与预后生存率无显著相关性。 展开更多
关键词 涎腺肿瘤 腺样囊性癌 预后 复发 神经侵袭
下载PDF
Pan-TRK免疫组化在涎腺分泌性癌中敏感性与特异性的临床病理分析
14
作者 倪皓 郭霞 +7 位作者 石晨曦 顾冬梅 庞培 詹升华 黄仁鹏 黄山 刘蔚 郭凌川 《临床与实验病理学杂志》 CAS 北大核心 2023年第1期53-57,共5页
目的探讨Pan-TRK免疫组化在涎腺分泌性癌(secretory carcinoma of salivary glands,SCSG)诊断及鉴别诊断中的价值。方法收集14例SCSG临床资料,采用免疫组化、FISH对SCSG进行检测。另选取经典的腺泡细胞癌、黏液表皮样癌、腺样囊性癌各1... 目的探讨Pan-TRK免疫组化在涎腺分泌性癌(secretory carcinoma of salivary glands,SCSG)诊断及鉴别诊断中的价值。方法收集14例SCSG临床资料,采用免疫组化、FISH对SCSG进行检测。另选取经典的腺泡细胞癌、黏液表皮样癌、腺样囊性癌各10例作为对照。结果14例SCSG患者男女比为4∶3,年龄15~79岁,10例发生于腮腺,2例发生于颊部,1例发生于腭部,1例发生于颈部;11例生存状态良好,1例复发生存,2例失访。14例SCSG,多呈浸润性生长,呈微囊状、乳头-囊状、管状、实性排列或几者混合,腔内伴丰富分泌物,1例见神经侵犯,1例伴淋巴结转移。免疫表型:14例SCSG中CK7、S-100、Mammaglobin均阳性,11例SOX-10阳性,10例GATA-3阳性,14例DOG1均阴性,Ki-67增殖指数为1%~15%。FISH检测:12例SCSG成功检测到FISH信号,10例发现ETV6-NTRK3基因融合阳性。14例SCSG均行Pan-TRK免疫组化检测,10例细胞核阳性,1例细胞质阳性。10例腺泡细胞癌、10例黏液表皮样癌、10例腺样囊性癌中分别有2、4、7例Pan-TRK阳性,定位于细胞膜/细胞质。结论Pan-TRK免疫组化阳性可提示伴ETV6-NTRK3融合的SCSG,尤其以细胞核着色模式为阳性标准时,在SCSG诊断及鉴别诊断中表现为较高的敏感性和高度特异性,并对未来TRK基因靶向治疗提供依据。 展开更多
关键词 涎腺肿瘤 分泌性癌 NTRK Pan-TRK 免疫组织化学 FISH
下载PDF
NR4A3和Pan-TRK免疫组化染色在涎腺腺泡细胞癌与分泌性癌鉴别诊断中的应用 被引量:1
15
作者 张晓红 刘晓江 +3 位作者 薛梅 陈方文 王志蕙 姚少波 《现代肿瘤医学》 CAS 北大核心 2023年第7期1237-1240,共4页
目的:探讨NR4A3、Pan-TRK免疫组化染色在涎腺腺泡细胞癌(acinic cell carcinoma,AciCC)、分泌性癌(secretory carcinoma of salivary gland,SCSG)鉴别诊断中的应用价值。方法:收集2010年03月至2021年01月我院病理科存档的22例AciCC、13... 目的:探讨NR4A3、Pan-TRK免疫组化染色在涎腺腺泡细胞癌(acinic cell carcinoma,AciCC)、分泌性癌(secretory carcinoma of salivary gland,SCSG)鉴别诊断中的应用价值。方法:收集2010年03月至2021年01月我院病理科存档的22例AciCC、13例SCSG及132例其它涎腺肿瘤,分别进行NR4A3、Pan-TRK免疫组化染色并分析表达情况。结果:NR4A3免疫组化染色显示AciCC(21/22)阳性,其中17例局灶/弥漫强阳,4例中等阳性,1例阴性。13例SCSG及其它132例涎腺肿瘤均(-)。Pan-TRK免疫组化显示13例SCSG均(+)、22例AciCC均(-)。NR4A3在AciCC中敏感性为95.5%,特异性为100%。结论:NR4A3是AciCC一种新标记物,特别与SCSG的鉴别诊断中,联合使用Pan-TRK,可进一步提高诊断的特异性。 展开更多
关键词 涎腺 腺泡细胞癌 分泌性癌 NR4A3 Pan-TRK
下载PDF
肾移植术后腮腺低分化黏液表皮样癌1例
16
作者 赵玲帆 周杨 +1 位作者 叶鑫鑫 张强 《国际口腔医学杂志》 CAS CSCD 2023年第4期419-422,共4页
黏液表皮样癌是唾液腺恶性肿瘤中最常见的肿瘤之一,而低分化黏液表皮样癌属于高度恶性肿瘤,较为少见。由于肾移植受者术后长期应用免疫抑制剂,故肾移植受者比普通人群更易发生恶性肿瘤,其中皮肤癌最为多见,而肾移植术后发生涎腺肿瘤较... 黏液表皮样癌是唾液腺恶性肿瘤中最常见的肿瘤之一,而低分化黏液表皮样癌属于高度恶性肿瘤,较为少见。由于肾移植受者术后长期应用免疫抑制剂,故肾移植受者比普通人群更易发生恶性肿瘤,其中皮肤癌最为多见,而肾移植术后发生涎腺肿瘤较为罕见。本文报道了1名肾移植术后6年,患腮腺低分化黏液表皮样癌的男性患者。该患者接受了手术切除治疗后,达到出院标准,顺利出院。随访21个月后,病变无复发。 展开更多
关键词 唾液腺 恶性肿瘤 黏液表皮样癌 肾移植
下载PDF
涎腺分泌性癌4例临床病理特征 被引量:8
17
作者 张雷 魏建国 +1 位作者 许梅 孔令非 《临床与实验病理学杂志》 CAS CSCD 北大核心 2018年第2期187-190,共4页
目的探讨涎腺分泌性癌(mammary analogue secretory carcinoma,MASC)的临床病理特征、免疫表型、诊断与鉴别诊断。方法回顾性分析4例MASC的临床病理学及免疫表型特征,并进行随访。结果 4例患者中2例女性,2例男性。年龄20~72岁,平均52.2... 目的探讨涎腺分泌性癌(mammary analogue secretory carcinoma,MASC)的临床病理特征、免疫表型、诊断与鉴别诊断。方法回顾性分析4例MASC的临床病理学及免疫表型特征,并进行随访。结果 4例患者中2例女性,2例男性。年龄20~72岁,平均52.2岁。4例镜下均呈浸润性生长,形成微囊、囊性-乳头状、腺管状或实性巢状、片状生长结构;部分腺管状腔内或微囊类似甲状腺滤泡;4例均未观察到坏死、神经或脉管侵犯现象。免疫表型:4例S-100蛋白、Mammaglobin、SOX10均呈弥漫强阳性;3例GATA-3弥漫强阳性;4例p63和DOG-1均阴性。结论 MASC是一种低度恶性的涎腺上皮源性肿瘤,免疫组化标记S-100蛋白、Mammaglobin、SOX10和DOG-1及联合应用对MASC的诊断及鉴别诊断有较大价值。 展开更多
关键词 涎腺肿瘤 乳腺样分泌性癌 分泌性癌 免疫组织化学
下载PDF
大涎腺上皮性肿瘤212例临床分析 被引量:6
18
作者 齐东元 高鹤立 +1 位作者 李全洪 王如 《口腔医学》 CAS 2004年第5期286-287,共2页
目的 总结大涎腺上皮性肿瘤的临床特点,指导临床实践。方法 按照WHO 1991年涎腺肿瘤组织学分类标准,对212例经病理确诊的大涎腺上皮性肿瘤进行回顾性临床分析,讨论良、恶性肿瘤的不同临床特征。结果 212例肿瘤中,腺瘤166例(78.3%),以... 目的 总结大涎腺上皮性肿瘤的临床特点,指导临床实践。方法 按照WHO 1991年涎腺肿瘤组织学分类标准,对212例经病理确诊的大涎腺上皮性肿瘤进行回顾性临床分析,讨论良、恶性肿瘤的不同临床特征。结果 212例肿瘤中,腺瘤166例(78.3%),以多形性腺瘤为主;涎腺癌46例(21.7%),以腺样囊性癌最多见。腮腺是最主要发病部位。涎腺腺瘤临床多表现为无痛性肿块,涎腺癌常伴有疼痛和(或)神经麻痹等症状。结论 大涎腺良、恶性肿瘤具有不同的临床特征,有助于临床正确诊断。 展开更多
关键词 大涎腺 腺瘤 涎腺癌 临床特征
下载PDF
下颌骨破坏为主要表现的腺泡细胞癌1例及文献复习 被引量:3
19
作者 杨兰 刘颜彬 +3 位作者 邢占奎 孙健 夏鑫 晏红 《实用口腔医学杂志》 CAS CSCD 北大核心 2011年第6期872-875,共4页
回顾性分析1例以下颌骨肿物就诊的腺泡细胞癌患者的病例资料,讨论此病的发病机制,诊断标准和治疗方法。该病发生于下颌骨十分罕见,目前手术是主要治疗手段,预后较好。
关键词 腺泡细胞癌 下颌骨 唾液腺肿瘤 组织病理 影像学
下载PDF
外耳道耵聍腺样囊性癌1例 被引量:3
20
作者 赵志飞 李建雄 +2 位作者 李方 石媛 尹航 《湖南中医药大学学报》 CAS 2014年第2期51-51,共1页
1 临床资料 耵聍腺肿瘤起源于外耳道耵聍腺,该肿瘤较少见,其中耵聍腺癌更罕见,据统计,在耳鼻喉部肿瘤1776例中,该病仅2例。该病自然病程较长,治疗以手术切除为主,但术后易复发。我科于2009年收治1例,行1次手术,复发后行粒子植... 1 临床资料 耵聍腺肿瘤起源于外耳道耵聍腺,该肿瘤较少见,其中耵聍腺癌更罕见,据统计,在耳鼻喉部肿瘤1776例中,该病仅2例。该病自然病程较长,治疗以手术切除为主,但术后易复发。我科于2009年收治1例,行1次手术,复发后行粒子植入1次,转移后行化疗4次,现报道如下。 展开更多
关键词 外耳道 耵聍腺肿瘤 化疗 腺样囊性癌
下载PDF
上一页 1 2 4 下一页 到第
使用帮助 返回顶部